Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists

被引:22
|
作者
Campbell, KM [1 ]
McGrath, MJ [1 ]
Burton, FH [1 ]
机构
[1] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
关键词
compulsive behavior; glutamate; obsessive-compulsive disorder (OCD); Tourette's syndrome; catalepsy; (mouse);
D O I
10.1016/S0014-2999(99)00184-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously created transgenic mice in which dopamine D-1 receptor-expressing (D1 +) neurons in regional subsets of the cortex and amygdala express a neuropotentiating cholera toxin (CT) transgene. These 'D1CT' mice engage in complex biting, locomotor and behavioral perseverance-repetition abnormalities that resemble symptoms of human compulsive disorders associated with cortical-limbic hyperactivity. Because excessive cortical-limbic stimulation of striatal motor pathways may play a critical role in causing compulsive disorders, we examined the responsiveness of D1CT mice to dopamine D-1 and D-2 receptor antagonists. D1CT mice were found to be largely resistant to the cataleptic action of the D-1 receptor antagonist SCH23390. The abnormal repetitive leaping of D1CT mice was similarly unaffected by SCH23390. In contrast, the DICT mice displayed supersensitivity to cataleptic induction by the D-2 receptor antagonist sulpiride. These data are consistent with the hypothesis that complex compulsions are mediated by chronic excessive corticostriatal (and/or amygdalostriatal) glutamatergic stimulation of the striatal direct and indirect motor pathways. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 50 条
  • [21] D1 AND D2 DOPAMINE RECEPTOR MECHANISMS IN DOPAMINERGIC BEHAVIORS
    KOLLER, WC
    HERBSTER, G
    CLINICAL NEUROPHARMACOLOGY, 1988, 11 (03) : 221 - 231
  • [22] DOPAMINE RECEPTOR SUBTYPES - BEYOND THE D1/D2 CLASSIFICATION
    ANDERSEN, PH
    GINGRICH, JA
    BATES, MD
    DEARRY, A
    FALARDEAU, P
    SENOGLES, SE
    CARON, MG
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (06) : 231 - 236
  • [23] Constitutive activity of a chimeric D2/D1 dopamine receptor
    Kozell, LB
    Neve, KA
    MOLECULAR PHARMACOLOGY, 1997, 52 (06) : 1137 - 1149
  • [24] Adolescent Maturation of D1 and D2 Dopamine Receptor Interactions
    Dwyer, Jennifer Buenzle
    Martinez, Lesly
    Ganddini, Gabriela
    Perez, Mayra
    Leslie, Frances M.
    FASEB JOURNAL, 2010, 24
  • [25] Evidence against dopamine D1/D2 receptor heteromers
    A L Frederick
    H Yano
    P Trifilieff
    H D Vishwasrao
    D Biezonski
    J Mészáros
    E Urizar
    D R Sibley
    C Kellendonk
    K C Sonntag
    D L Graham
    R J Colbran
    G D Stanwood
    J A Javitch
    Molecular Psychiatry, 2015, 20 : 1373 - 1385
  • [26] D1/D2 DOPAMINE RECEPTOR INTERACTION AT THE BIOCHEMICAL LEVEL
    STRANGE, PG
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (02) : 48 - 49
  • [27] DIFFERENTIAL AFFINITY OF DOPAMINERGIC AGONISTS AND ANTAGONISTS FOR D1 AND D2 DOPAMINE-RECEPTORS IN RAT STRIATUM
    CARBONI, E
    MEMO, M
    SPANO, PF
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1983, 15 (07): : 697 - 706
  • [28] Sensitivities of dopamine D1 and D2 receptor radioligands to changes in synaptic dopamine
    Gifford, AN
    Gatley, SJ
    Shea, C
    Ashby, CR
    Volkow, ND
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 927 - 927
  • [29] Comparative effects of dopamine D1 and D2 receptor antagonists on nerve growth factor protein induction
    Ozaki, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 402 (1-2) : 39 - 44
  • [30] Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors
    Dall'Olio, R
    Gaggi, R
    Voltattorni, M
    Tanda, A
    Gandolf, O
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08): : 633 - 638